Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  BENKOWITZ MICHAEL
 2. Date of Event Requiring Statement (Month/Day/Year)
06/26/2016		 3. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [UTHR]
(Last)
(First)
(Middle)
C/O UNITED THERAPEUTICS CORPORATION, 1040 SPRING STREET		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President and COO
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SILVER SPRING, MD 20910		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1,088
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Share Tracking Award 01/02/2018(1) 01/02/2023 Common Stock 100,000 $ 53.83 D  
Share Tracking Award 03/13/2016(2) 03/13/2025 Common Stock 37,200 $ 163.3 D  
Share Tracking Award 03/14/2015(3) 03/14/2024 Common Stock 40,000 $ 94.96 D  
Share Tracking Award 03/15/2013(4) 03/15/2022 Common Stock 6,450 $ 47.5 D  
Share Tracking Award 03/15/2014(5) 03/15/2023 Common Stock 18,400 $ 61.06 D  
Stock Options 03/15/2017(6) 03/15/2026 Common Stock 39,200 $ 120.26 D  
Share Tracking Award 04/04/2012(7) 04/04/2021 Common Stock 21,750 $ 68.14 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
BENKOWITZ MICHAEL
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING, MD 20910		       President and COO  

Signatures

/s/ John S. Hess, Jr. under Power of Attorney 06/27/2016
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) These share tracking awards cliff vest on January 2, 2018, and settle in cash only.
(2) These share tracking awards vest in one-fourth increments on each of March 13, 2016, 2017, 2018 and 2019, and settle in cash only.
(3) These share tracking awards vest in one-fourth increments on each of March 14, 2015, 2016, 2017 and 2018, and settle in cash only. Of the outstanding awards, 20,000 are vested as of the date of this filing.
(4) These share tracking awards vested in one-fourth increments on each of March 15, 2013, 2014, 2015 and 2016, and settle in cash only. All of the remaining awards are fully vested.
(5) These share tracking awards vest in one-fourth increments on each of March 15, 2014, 2015, 2016 and 2017, and settle in cash only. Of the outstanding awards, 9,200 are vested as of the date of this filing, and the remaining 9,200 are expected to vest on March 15, 2017.
(6) These stock options vest in one-fourth increments on each of March 15, 2017, 2018, 2019 and 2020.
(7) These share tracking awards vested in one-fourth increments on each of April 4, 2012, 2013, 2014 and 2015, and settle in cash only. All remaining awards are fully vested.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.